BACKGROUND: Evidence suggests that the risk of breast and prostate cancer is increased among those with a family history of the same disease and particularly among first-degree relatives. However, less is known about the relationship between breast and prostate cancer within families and particularly among minority populations. METHODS: Analyses of participants in the Women's Health Initiative observational cohort who were free of breast cancer at the time of their baseline examination were conducted. Subjects were followed for breast cancer through August 31, 2009. A Cox proportional hazards regression modeling approach was used to estimate the risk of breast cancer associated with a family history of prostate cancer, breast cancer, and both among first-degree relatives. RESULTS: There were 78,171 eligible participants, and 3506 breast cancer cases were diagnosed during the study period. A family history of prostate cancer was associated with a modest increase in breast cancer risk after adjustments for confounders (adjusted hazard ratio [aHR], 1.14; 95% confidence interval [CI], 1.02-1.26). In a separate analysis examining the joint impact of both cancers, a family history of both breast and prostate cancer was associated with a 78% increase in breast cancer risk (aHR, 1.78; 95% CI, 1.45-2.19). Risk estimates associated with a family history of both breast and prostate cancer were higher among African American women (aHR, 2.34; 95% CI, 1.09-5.02) versus white women (aHR, 1.66; 95% CI, 1.33-2.08). CONCLUSIONS: These findings suggest that prostate cancer diagnosed among first-degree family members increases a woman's risk of developing breast cancer. Future studies are needed to determine the relative contributions of genes and a shared environment to the risk for both cancers.
BACKGROUND: Evidence suggests that the risk of breast and prostate cancer is increased among those with a family history of the same disease and particularly among first-degree relatives. However, less is known about the relationship between breast and prostate cancer within families and particularly among minority populations. METHODS: Analyses of participants in the Women's Health Initiative observational cohort who were free of breast cancer at the time of their baseline examination were conducted. Subjects were followed for breast cancer through August 31, 2009. A Cox proportional hazards regression modeling approach was used to estimate the risk of breast cancer associated with a family history of prostate cancer, breast cancer, and both among first-degree relatives. RESULTS: There were 78,171 eligible participants, and 3506 breast cancer cases were diagnosed during the study period. A family history of prostate cancer was associated with a modest increase in breast cancer risk after adjustments for confounders (adjusted hazard ratio [aHR], 1.14; 95% confidence interval [CI], 1.02-1.26). In a separate analysis examining the joint impact of both cancers, a family history of both breast and prostate cancer was associated with a 78% increase in breast cancer risk (aHR, 1.78; 95% CI, 1.45-2.19). Risk estimates associated with a family history of both breast and prostate cancer were higher among African American women (aHR, 2.34; 95% CI, 1.09-5.02) versus white women (aHR, 1.66; 95% CI, 1.33-2.08). CONCLUSIONS: These findings suggest that prostate cancer diagnosed among first-degree family members increases a woman's risk of developing breast cancer. Future studies are needed to determine the relative contributions of genes and a shared environment to the risk for both cancers.
Authors: Michael S Simon; Jeannette F Korczak; Cecilia L Yee; Kathleen E Malone; Giske Ursin; Leslie Bernstein; Jill A McDonald; Dennis Deapen; Brian L Strom; Michael F Press; Polly A Marchbanks; Ronald T Burkman; Linda K Weiss; Ann G Schwartz Journal: J Clin Oncol Date: 2006-06-01 Impact factor: 44.544
Authors: K L Nastiuk; M Mansukhani; M B Terry; P Kularatne; M A Rubin; J Melamed; M D Gammon; M Ittmann; J J Krolewski Journal: Prostate Date: 1999-08-01 Impact factor: 4.104
Authors: Jennifer L Beebe-Dimmer; Elizabeth A Drake; Rodney L Dunn; Cathryn H Bock; James E Montie; Kathleen A Cooney Journal: Urology Date: 2006-11-07 Impact factor: 2.649
Authors: I Agalliu; E Karlins; E M Kwon; L M Iwasaki; A Diamond; E A Ostrander; J L Stanford Journal: Br J Cancer Date: 2007-08-14 Impact factor: 7.640
Authors: Traci N Bethea; Lynn Rosenberg; Nelsy Castro-Webb; Kathryn L Lunetta; Lara E Sucheston-Campbell; Edward A Ruiz-Narváez; Marjory Charlot; Song-Yi Park; Elisa V Bandera; Melissa A Troester; Christine B Ambrosone; Julie R Palmer Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-31 Impact factor: 4.254
Authors: Matthew B Clements; Emily A Vertosick; Lourdes Guerrios-Rivera; Amanda M De Hoedt; Javier Hernandez; Michael A Liss; Robin J Leach; Stephen J Freedland; Alexander Haese; Francesco Montorsi; Stephen A Boorjian; Cedric Poyet; Donna P Ankerst; Andrew J Vickers Journal: Eur Urol Date: 2021-12-31 Impact factor: 24.267
Authors: Kristen S Purrington; Ann G Schwartz; Julie J Ruterbusch; Mark A Manning; Mrudula Nair; Angela S Wenzlaff; Stephanie S Pandolfi; Michael S Simon; Jennifer Beebe-Dimmer Journal: Cancer Date: 2020-08-04 Impact factor: 6.860
Authors: Lauren Barber; Travis Gerke; Sarah C Markt; Samuel F Peisch; Kathryn M Wilson; Thomas Ahearn; Edward Giovannucci; Giovanni Parmigiani; Lorelei A Mucci Journal: Clin Cancer Res Date: 2018-08-06 Impact factor: 12.531
Authors: Jennifer L Beebe-Dimmer; Cecilia Yee; Electra Paskett; Ann G Schwartz; Dorothy Lane; Nynikka R A Palmer; Cathryn H Bock; Rami Nassir; Michael S Simon Journal: BMC Cancer Date: 2017-12-13 Impact factor: 4.430